These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9406577)

  • 1. Development of myeloma and secondary myelodysplastic syndrome from a common clone.
    Schmetzer HM; Mittermüller J; Duell T; Wilmanns W
    Cancer Genet Cytogenet; 1998 Jan; 100(1):31-5. PubMed ID: 9406577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy-related myelodysplastic syndrome. Two cytogenetically unrelated abnormal clones in a patient with multiple myeloma.
    Abeliovich D; Yehuda O; Ben-Neriah S; Matzner Y
    Cancer Genet Cytogenet; 1993 Oct; 70(2):117-9. PubMed ID: 8242590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of myelodysplastic syndrome clones arising after multiple myeloma: a case study by correlative interphase cytogenetic analysis.
    Kobayashi Y; Nakayama M; Uemura N; Takeyama K; Tobinai K; Takenaka T; Choi SH; Satoh H; Mori S; Asano S
    Jpn J Clin Oncol; 1999 Aug; 29(8):374-7. PubMed ID: 10494920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDS/AML-associated cytogenetic abnormalities in multiple myeloma and monoclonal gammopathy of undetermined significance: evidence for frequent de novo occurrence and multipotent stem cell involvement of del(20q).
    Nilsson T; Nilsson L; Lenhoff S; Rylander L; Astrand-Grundström I; Strömbeck B; Höglund M; Turesson I; Westin J; Mitelman F; Jacobsen SE; Johansson B
    Genes Chromosomes Cancer; 2004 Nov; 41(3):223-31. PubMed ID: 15334545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
    Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
    Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetic abnormalities in acute leukemia complicating melphalan-treated multiple myeloma.
    Rödjer S; Swolin B; Weinfeld A; Westin J
    Cancer Genet Cytogenet; 1990 Aug; 48(1):67-73. PubMed ID: 2372790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent Abnormal Clones in Myelodysplastic Syndrome Marrow Originate from Cells at a Pluripotent Stem Level and Maintain Their Early Differentiation Potency.
    Qi H; Qingxia Z; Xiao L; Lingyun W; Feng X; Zheng Z; Chunkang C
    Cancer Invest; 2015; 33(8):369-77. PubMed ID: 26135215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biclonal chromosomal aberrations in a child with myelodysplastic syndrome.
    Jakab Z; Balogh E; Kiss C; Pajor L; Oláh E
    Cancer Genet Cytogenet; 1999 Jan; 108(1):13-8. PubMed ID: 9973918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion 5q31 in patients with stable, melphalan-treated multiple myeloma.
    Amiel A; Fridman K; Elis A; Gaber E; Manor Y; Fejgin M; Lishner M
    Cancer Genet Cytogenet; 1999 Aug; 113(1):45-8. PubMed ID: 10459345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal karyotype evolution involving ring chromosome 1 with myelodysplastic syndrome subtype RAEB-t progressing into acute leukemia.
    Duell T; Poleck-Dehlin B; Schmid C; Wunderlich B; Ledderose G; Mittermuller J; Kolb HJ; Schmetzer H
    Acta Haematol; 2006; 116(2):131-6. PubMed ID: 16914909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.
    Ishii Y; Hsiao HH; Sashida G; Ito Y; Miyazawa K; Kodama A; Ohyashiki JH; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Jun; 167(2):131-7. PubMed ID: 16737912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
    Bernell P; Jacobsson B; Nordgren A; Hast R
    Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplasia during the course of myeloma. Restriction of 17p deletion and p53 overexpression to myeloid cells.
    Soenen V; Preudhomme C; Roumier C; Laï JL; Lepelley P; Facon T; Pagniez D; Fenaux P
    Leukemia; 1998 Feb; 12(2):238-41. PubMed ID: 9519788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the pathogenesis of myelodysplastic syndromes.
    Delforge M
    Hematol J; 2003; 4(5):303-9. PubMed ID: 14502253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional cytogenetics and fluorescence in situ hybridization in persistent cytopenias and myelodysplastic syndromes in childhood.
    Touliatou V; Kolialexi A; Tsangaris GT; Moschovi M; Polychronopoulou S; Mavrou A
    Anticancer Res; 2004; 24(6):3945-9. PubMed ID: 15736436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of chromosome 1 pericentric heterochromatin (1q) in pathogenesis of myelodysplastic syndromes: report of 2 new cases.
    Millington K; Hudnall SD; Northup J; Panova N; Velagaleti G
    Exp Mol Pathol; 2008 Apr; 84(2):189-93. PubMed ID: 18339374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance.
    Schanz J; Solé F; Mallo M; Luño E; Cervera J; Granada I; Hildebrandt B; Slovak ML; Ohyashiki K; Fonatsch C; Pfeilstöcker M; Nösslinger T; Valent P; Giagounidis A; Aul C; Lübbert M; Stauder R; Krieger O; Le Beau MM; Bennett JM; Greenberg P; Germing U; Haase D
    Genes Chromosomes Cancer; 2018 Nov; 57(11):547-556. PubMed ID: 30248204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.
    Martínez-Climent JA; Comes AM; Vizcarra E; Benet I; Arbona C; Prósper F; Solano C; García Clavel B; Marugán I; Lluch A; García-Conde J
    Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Karyotypically unrelated clones in acute leukemias and myelodysplastic syndromes.
    Kobayashi H; Kaneko Y; Maseki N; Sakurai M
    Cancer Genet Cytogenet; 1990 Jul; 47(2):171-8. PubMed ID: 2357693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.